Skip to content
Log In

Command Dialog

Insilico Medicine

SERIES
Series E
hong kong, china
Last funded
Active

ai drug discovery, biomedical ai

Latest Funding
Series E
$110 million
Valuation
$1.0+ billion

Market Focus

Series E

AI Products

Pharma.AI drug discovery platform

AI Capabilities

Growth Predictions

Company Information

Company Name
Insilico Medicine
Headquarters
hong kong, china

Startup Stats

Stage
SERIES
Locationhong kong, china
Market StageSeries E
Last Funding

Similar Startups